New Precision Oncology Tests to Drive Personalised Therapies and Improved Treatment Outcomes
April 17, 2024 08:00 ET
|
Genetic Technologies Ltd
New Precision Oncology Tests to Drive Personalised Therapies and Improved Treatment Outcomes
Prelude Highlights Continued Strength of Discovery Engine at 2024 AACR Annual Meeting
April 09, 2024 16:35 ET
|
Prelude Therapeutics, Inc.
Highly selective oral SMARCA2 degrader, PRT7732, shows robust anti-tumor activity in vivo as monotherapy and in combination with chemotherapy, at well-tolerated doses Potentially best-in-class CDK9...
Global Orphan Drug Sector Poised for Growth Amidst Unmet Rare Disease Needs
April 05, 2024 04:04 ET
|
Research and Markets
Dublin, April 05, 2024 (GLOBE NEWSWIRE) -- The "Global Orphan Drug Growth Opportunities" report has been added to ResearchAndMarkets.com's offering. This study provides critical insights into the...
Innovation Waves in Immuno-oncology Therapy Development - Next-gen Cell Therapies and Precision Immunotherapies are Driving Growth and New Product Development
March 21, 2024 05:13 ET
|
Research and Markets
Dublin, March 21, 2024 (GLOBE NEWSWIRE) -- The "Innovation Waves in Immuno-oncology Therapy Development" report has been added to ResearchAndMarkets.com's offering. Immuno-oncology (I-O)...
Omics Lab Services Market Forecast Report 2024-2029: 15% CAGR Forecast During 2024-2029, with Notable Developments in Cancer Research and Genomics
March 15, 2024 05:09 ET
|
Research and Markets
Dublin, March 15, 2024 (GLOBE NEWSWIRE) -- The "Omics Lab Services Market - Forecasts from 2024 to 2029" report has been added to ResearchAndMarkets.com's offering.The omics lab services market was...
Bayer and Aignostics to collaborate on next generation precision oncology
March 14, 2024 03:30 ET
|
Aignostics GmbH
Not intended for UK Media Strategic multi-year research collaboration to identify novel targets with strong disease links and to accelerate clinical development, further strengthening Bayer’s...
Epigenetics Market Research Report 2023 - Global Forecast to 2030 with Market Share Analysis of Merck, 10X Genomics, Thermo Fisher Scientific, Illumina, and QIAGEN
March 01, 2024 04:11 ET
|
Research and Markets
Dublin, March 01, 2024 (GLOBE NEWSWIRE) -- The "Epigenetics Market by Offering (Kits, Reagents, Instruments, Software) Method (DNA Methylation, PCR, Chromatin Analysis, Histone, RNA Modification),...
Genomic Cancer Panel and Profiling Market Set to Reach $26.59 Billion by 2033, Fueled by Advances in Precision Medicine
February 27, 2024 11:44 ET
|
Research and Markets
Dublin, Feb. 27, 2024 (GLOBE NEWSWIRE) -- The "Genomic Cancer Panel and Profiling Market - A Global and Regional Analysis: Focus on Tissue Testing, Cancer Panel Type, Cancer Type, Application,...
Global Precision Oncology Market Report 2023: Technological Innovations Propel Growth Opportunities
January 30, 2024 11:28 ET
|
Research and Markets
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "Global Precision Oncology Market Trends and Growth Opportunities" report has been added to ResearchAndMarkets.com's offering. The emergence of...
Oncology Precision Medicine Market Projected to Surpass $123 Billion by 2028, Driven by Technological Innovations and Personalized Treatment Approaches
January 29, 2024 06:49 ET
|
Research and Markets
Dublin, Jan. 29, 2024 (GLOBE NEWSWIRE) -- The "Oncology Precision Medicine Market, Size, Global Forecast 2023-2028, Industry Trends, Growth, Share, Outlook, Impact of Inflation, Opportunity Company...